Renalytix (RENX) Stock Statistics & Valuation Metrics

Renalytix has a market cap or net worth of $26.50M. The enterprise value is 34.47M.

Renalytix has 331,206,020 shares outstanding. The number of shares has decreased by -2.65% in one year.

Renalytix’s return on equity (ROE) is 4.26 and return on invested capital (ROIC) is -4348.24%.

The current PE Ratio of Renalytix is -0.45. Renalytix’s PEG ratio is 0.01.

In the last 12 months, Renalytix had revenue of 2.29M and earned -33.46M in profits. Earnings per share was -0.31.

In the last 12 months, operating cash flow was -23.02M and capital expenditures -1.00K, giving a free cash flow of -18.16M billion.

Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―

Renalytix upcoming earnings date is Jun 17, 2025, TBA Not Confirmed.

Renalytix as a current ratio of 0.53, with Debt / Equity ratio of -599.34%

In the past 12 months, Renalytix has paid 4.00K in taxes.

Renalytix EV to EBITDA ratio is -0.66, with an EV/FCF ratio of -0.63.

Renalytix has $9.63M in cash and marketable securities with $8.21M in debt, giving a net cash position of -$1.42M billion.

Gross margin is 19.73%, with operating margin of -1293.49%, and net profit margin of -1461.60%.

The average price target for Renalytix is ―, which is 11.43% higher than the current price. The consensus rating is ―